Clinical Research Drug Development Therapies Webinar 
Drug Discovery World
OCTOBER 17, 2023
The presentation will address important issues in antibody drug development, including choosing the right biomarker, drug formulation and manufacturing. Muaiad Kittaneh Dreps and Kittaneh will also explore the importance of collaboration and data sharing in antibody drug development.
Conversations in Drug Development Trends
JUNE 21, 2024
The 2024 ASCO Annual Meeting from the American Society of Clinical Oncology is a fantastic platform for clinical researchers to discuss the latest advancements and challenges in oncology research. Currently, there are 12 approved ADC drugs, and several hundred more are in the development pipeline.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Conversations in Drug Development Trends
FEBRUARY 22, 2023
Our rare disease team at Worldwide will be hosting a panel discussion webinar with patient advocates active in Rare Disease Day events to synthesize the most salient conversations taking place. See their conversation below and register for the webinar to hear more from these advocates!
PPD
OCTOBER 16, 2023
There has been continuous growth in the variety and volume of available health care data, and newer applications for use of real-world data (RWD) and real-world evidence (RWE) to enhance the speed of patient access to new therapies. Tokenization can accelerate innovation in clinical trials and drug development.
Alta Sciences
JULY 18, 2023
Top Nonclinical Scientific Resources The Altascientist Issue 32: A Changing Paradigm for Non-rodent Species in Nonclinical Safety Studies Though historically used predominantly in dermal and wound healing research, an increasing body of evidence supports the use of miniature swine as a viable non-rodent option for your nonclinical safety studies.
Conversations in Drug Development Trends
MAY 1, 2024
For clinical research professionals, this journey often involves reconciling differing feedback from regulatory agencies, each with unique standards, priorities, and expectations. Check out our recent webinar for a more comprehensive dive into early and ongoing regulatory engagement and how it drives program and commercial success.
PPD
SEPTEMBER 16, 2024
The convergence of real-world data (RWD), technology and artificial intelligence (AI) is playing a vital role in accelerating drug development. In a recent panel discussion at DIA Global , our experts explored how these elements are reshaping clinical research and drug discovery.
Expert insights. Personalized for you.
130 
Let's personalize your content